Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease | MicrobiomeTrials← Back to trialsNCT07646197
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-09Est. Completion: 2028-04-06
Enrollment target: 125 participants Locations- Henry Ford Health System, Detroit, Michigan, United States
Other microbiome trials you might be interested in
MASLDHIV (Human Immunodeficiency Virus)
Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver disease, is increasingly…
Shanghai, ChinaEst. completion Sep 1, 2026
Fatty Liver
The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of…
Sohag, EgyptEst. completion Jan 1, 2027